NYSE · EHC
Healthcare · Medical - Care Facilities
$122.00
Down-$0.53 (-0.43%)
Updated Sep 16, 2026, 11:39 AM
SID Score
6.3/10
Composite research score
Smart Money
58/100
Neutral
Price performance
1M range · 20 trading sessions · Daily adjusted prices
EHC closed at $122.00 after 20 trading sessions, down 0.08% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $121.89 | $122.98 | $119.695 | $122.00 | 791.78K |
| Sep 14, 2026 | $123.05 | $123.96 | $122.48 | $122.53 | 747.88K |
| Sep 11, 2026 | $122.02 | $122.595 | $120.69 | $121.71 | 649.32K |
| Sep 10, 2026 | $122.49 | $124.25 | $120.42 | $121.04 | 710.77K |
| Sep 9, 2026 | $120.00 | $121.63 | $118.9975 | $121.52 | 621.04K |
| Sep 8, 2026 | $120.68 | $122.03 | $120.012 | $120.47 | 805.16K |
| Sep 4, 2026 | $121.53 | $122.62 | $121.53 | $121.79 | 517.75K |
| Sep 3, 2026 | $121.99 | $123.15 | $121.06 | $122.59 | 759.69K |
| Sep 2, 2026 | $121.87 | $122.79 | $120.63 | $121.18 | 650.84K |
| Sep 1, 2026 | $121.34 | $122.585 | $120.13 | $122.05 | 1.03M |
| Aug 31, 2026 | $120.44 | $122.1425 | $119.10 | $120.21 | 720.7K |
| Aug 28, 2026 | $120.43 | $121.66 | $118.99 | $120.85 | 887.89K |
| Aug 27, 2026 | $120.06 | $120.89 | $118.765 | $119.57 | 858.13K |
| Aug 26, 2026 | $120.19 | $122.03 | $119.06 | $120.78 | 1.68M |
| Aug 25, 2026 | $120.64 | $121.12 | $119.32 | $120.14 | 523.84K |
| Aug 24, 2026 | $120.71 | $122.32 | $120.28 | $120.92 | 689.48K |
| Aug 21, 2026 | $120.93 | $122.32 | $120.10 | $120.31 | 690.45K |
| Aug 20, 2026 | $120.99 | $123.18 | $120.53 | $120.91 | 766.25K |
| Aug 19, 2026 | $122.63 | $123.2943 | $121.065 | $121.74 | 825.64K |
| Aug 18, 2026 | $123.45 | $123.95 | $121.79 | $122.10 | 1.09M |
The latest Smart Investors Daily articles mentioning EHC.
EHC research
Company profile and research snapshot.
Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. These hospitals are concentrated in the eastern half of the United States and Texas.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 10, 2026 | TD Cowen | Buy | — |
| Aug 7, 2026 | UBS | Buy | — |
| Aug 7, 2026 | Truist Securities | Buy | — |
| Aug 6, 2026 | Barclays | Overweight | — |
| May 28, 2026 | TD Cowen | Buy | — |
No generated briefing is available yet.
Yahoo · Sep 7, 2026
On August 5, Encompass Health (NYSE:EHC) reported second quarter results that beat its own expectations by enough to raise full year guidance twice in the same release, first on revenue and then on profit. Net operating revenue climbed 9.6% to $1.597 billion, and adjusted earnings per share rose 10.7% to $1.55. For the largest owner […]
Yahoo · Sep 4, 2026
Encompass Health (EHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
SeekingAlpha · Aug 28, 2026
Encompass Health is rated a Buy due to its compelling growth prospects, operational excellence, and strong position. Read more on EHC stock here.
Yahoo · Aug 27, 2026
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have returned 24.9% over the past six months, topping the S&P 500 by 13.3 percentage points.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning EHC.
